10:17 AM EDT, 04/04/2024 (MT Newswires) -- John M. Evans, Director, CEO, on April 01, 2024, sold 18,102 shares in Beam Therapeutics ( BEAM ) for $581,617. Following the Form 4 filing with the SEC, Evans has control over a total of 1,161,343 shares of the company, with 1,058,343 shares held directly and 103,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1745999/000095017024041432/xslF345X03/ownership.xml

Price: 29.98, Change: +0.30, Percent Change: +1.01